Recognizing this reluctance, it is important to analyze the barriers associated with integrating these treatments into routine clinical practice to enhance cardiovascular outcomes [71]
Additionally, GLP-1 RAs modulate the hypothalamus (the region in the brain that controls appetite) to regulate hunger, slow gastric emptying, and regulate gut hormones such as leptin (a hormone that helps regulate body weight on a long-term basis)
It's a medically supervised protocol that begins with a comprehensive metabolic and cardiovascular labs panel, a clinician consultation to assess your specific goals and risk profile, and a personalized titration schedule designed to maximize outcomes while minimizing side effects
Anxiety related to tirzepatide may also increase in unfamiliar travel environments
For patients who have an obesity issue and binge eating disorder, sometimes the binge eating will correct itself with the GLP-1 agonist, but not always, Garcia-Webb says